TITLE

Bronchoscopy in haematopoietic stem cell transplant recipients may not be beneficial

AUTHOR(S)
Eccersley, Lydia R. J.
PUB. DATE
August 2007
SOURCE
Thorax;Aug2007, Vol. 62 Issue 8, p683
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a study which examines the significance of bronchoscopy to haemopoietic stem cell transplant (HSCT) recipients. It aimed to assess whether modifications in management-based on bronchoscopy results led to a survival advantage. The subject of the study were 1651 HSCT recipients. Results revealed that bronchoscopy in HSCT individual may not be beneficial.
ACCESSION #
26359984

 

Related Articles

  • Noroviruses as a Potential Cause of Protracted and Lethal Disease in Immunocompromised Patients. Koo, Hoonmo L.; DuPont, Herbert L. // Clinical Infectious Diseases;10/1/2009, Vol. 49 Issue 7, p1069 

    In this article the author discusses the study which determines the significance of noroviruses in protracted and lethal disease in immunocompromised hosts. The researchers have demonstrated that noroviruses cause persistent gastroenteritis in adult allogeneic hematopoietic stem cell transplant...

  • Can determination of gene polymorphism be of practical value in tailoring the treatment of HSCT patients? Lange, A; Jaskula, E // Bone Marrow Transplantation;Feb2015, Vol. 50 Issue 2, p161 

    The authors reflect on a study which examines the importance of determining the polymorphism of genes encoding proteins in tailoring the treatment of hematopoietic stem cell transplantation (HSCT) patients. They indicate that the determination of the allelic diversity of individuals may help in...

  • Palifermin in a hematopoietic stem cell transplant patient with osteonecrosis of the jaw. Yageman, Leah A.; Cronin, Simon M.; Peres, Edward; Abidi, Muneer H.; Ibrahim, Rami B. // Journal of Oncology Pharmacy Practice;Jun2006, Vol. 12 Issue 2, p119 

    This case report describes the use of palifermin in a multiple myeloma patient with a history of osteonecrosis of the jaw (ONJ) for the prevention of high-dose chemotherapy-induced mucositis. Following the day of autologous stem cell infusion, palifermin was discontinued secondary to adverse...

  • Factors associated with hematopoietic cell transplantation (HCT) among patients in a population-based study of myelodysplastic syndrome (MDS) in Minnesota. Smith, Angela; Warlick, Erica; Roesler, Michelle; Poynter, Jenny; Richardson, Michaela; Nguyen, Phuong; Cioc, Adina; Hirsch, Betsy; Ross, Julie // Annals of Hematology;Oct2015, Vol. 94 Issue 10, p1667 

    Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disorder characterized by dysplastic changes in the bone marrow, ineffective erythropoiesis, and an increased risk of developing acute myeloid leukemia. Treatment planning for patients with MDS is a complex process, and we sought...

  • How we approach patient evaluation for hematopoietic stem cell transplantation. Hamadani, M.; Craig, M.; Awan, F. T.; Devine, S. M. // Bone Marrow Transplantation;Aug2010, Vol. 45 Issue 8, p1259 

    The evaluation of patients for hematopoietic stem cell transplantation is a complex process. The decision to recommend transplantation is not simply dependent on patient diagnosis; instead it is a specialized analytic decision process intricately dependent on a number of variables including...

  • Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support. Milpied, Noel; Deconinck, Eric; Gaillard, Fanny; Delwail, Vincent; Foussard, Charles; Berthou, Christian; Gressin, Remy; Lucas, Virginie; Colombat, Philippe; Harousseau, Jean-Luc // New England Journal of Medicine;3/25/2004, Vol. 350 Issue 13, p1287 

    Background: The efficacy of first-line intensive chemotherapy plus transplantation of autologous hematopoietic stem cells in adults with disseminated aggressive lymphoma is unknown. Methods: We compared high-dose therapy plus autologous stem-cell support with the standard regimen of...

  • Traumeel S in preventing and treating mucositis in young patients undergoing SCT: a report of the Children's Oncology Group. Sencer, S F; Zhou, T; Freedman, L S; Ives, J A; Chen, Z; Wall, D; Nieder, M L; Grupp, S A; Yu, L C; Sahdev, I; Jonas, W B; Wallace, J D; Oberbaum, M // Bone Marrow Transplantation;Nov2012, Vol. 47 Issue 11, p1409 

    Mucositis can be a serious complication of hematopoietic SCT (HSCT). A previous phase II trial in 32 children undergoing HSCT reported a beneficial effect of the homeopathic remedy Traumeel S. The Children's Oncology Group sought to replicate the results in a multi-institutional trial. The study...

  • Use of Long-Term Suppressive Acyclovir after Hematopoietic Stem-Cell Transplantation: Impact on Herpes Simplex Virus (HSV) Disease and Drug-Resistant HSV Disease. Erard, Veronique; Wald, Anna; Corey, Lawrence; Leisenring, Wendy M.; Boeckh, Michael // Journal of Infectious Diseases;7/15/2007, Vol. 196 Issue 2, p266 

    The effect that long-term use of suppressive acyclovir (ACV) has on both overall herpes simplex virus (HSV) disease and ACV-resistant HSV disease was examined in 3 consecutive cohorts of hematopoietic stem-cell transplant (HCT) recipients ( ); cohort 1 received ACV for 30 days after np2049 HCT,...

  • Human stem cell therapy in ischaemic stroke: a review. Banerjee, Soma; Williamson, Deborah; Habib, Nagy; Gordon, Myrtle; Chataway, Jeremy // Age & Ageing;Jan2011, Vol. 40 Issue 1, p7 

    Stroke is a leading cause of death and disability. Globally, 15 million people suffer a stroke each year, of whom more than 5 million die, and a further 5 million are left permanently disabled. Current treatment options offer modest benefits, and there is a pressing need for new and effective...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics